UPLOAD Filing
Lyra Therapeutics, Inc.
Date: July 28, 2025 · CIK: 0001327273 · Accession: 0000000000-25-007914
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288872
Letter
Re: Lyra Therapeutics, Inc. Registration Statement on Form S-1 Filed July 22, 2025 File No. 333-288872 Dear Maria Palasis Ph.D.:
July 28, 2025
Maria Palasis, Ph.D. Chief Executive Officer Lyra Therapeutics, Inc. 480 Arsenal Way Watertown, MA 02472
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Juan Grana at 202-551-6034 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Industrial
Applications and
Services
cc: Wesley C. Holmes, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> July 28, 2025 Maria Palasis, Ph.D. Chief Executive Officer Lyra Therapeutics, Inc. 480 Arsenal Way Watertown, MA 02472 Re: Lyra Therapeutics, Inc. Registration Statement on Form S-1 Filed July 22, 2025 File No. 333-288872 Dear Maria Palasis Ph.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Juan Grana at 202-551-6034 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Wesley C. Holmes, Esq. </TEXT> </DOCUMENT>